i.vogel
Submits third-party assay reports on material purchased directly. Based in Linköping.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.08%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041311 | Ipamorelin | WWB | WWB-2604-E3153 | Janoshik | 2026-Q2 | 99.78 | 5.65 | 106.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042394 | GHRP-2 | Homopeptide | HOMO-2602-E3918 | Janoshik | 2026-Q2 | 99.93 | 4.41 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042849 | Tirzepatide | GGPeps | GGPE-2510-L2662 | Medutest | 2026-Q1 | 97.98 | 4.60 | 98.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-019446 | N-Acetyl Semax Amide | JEEP | JEEP-2507-U8215 | Janoshik | 2025-Q4 | 99.93 | 8.31 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018488 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | Janoshik | 2025-Q4 | 99.63 | 3.14 | 95.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020200 | TB-500 | ERP | ERP-2509-K9340 | Janoshik | 2025-Q4 | 99.12 | 2.48 | 106.3 | Laboratory-retained | 0 | PASS |
| AX-2025-019935 | Semaglutide | HJ | HJ-2507-Y6433 | Janoshik | 2025-Q3 | 98.39 | 3.41 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020841 | KPV | CPC | CPC-2502-M2176 | Janoshik | 2025-Q3 | 98.31 | 3.20 | 91.1 | Buyer-sourced | 0 | FAIL |
| AX-2025-018750 | CJC-1295 (no DAC) | QSC | QSC-2411-D7855 | VendorInvestigate | 2025-Q1 | 99.02 | 3.81 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005030 | TB-500 | KP | KP-2407-V6115 | Janoshik | 2024-Q4 | 99.04 | 4.72 | 104.0 | Buyer-sourced | 1 | FAIL |